tramadol has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JL; Huang, YH; Lai, HC; Liu, LC; Wu, ZF; Wu, ZS | 1 |
| Balkan, B; Çetingök, H; Comba, C; Demirayak, G; Hergünsel, GO; Özdemir, İA; Yener, YZ | 1 |
2 other study(ies) available for tramadol and Endometrial Neoplasms
| Article | Year |
|---|---|
Mitochondrial Dysfunction Involved in the Cytotoxicity of Tramadol in Human Endometrial Carcinoma Cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Endometrial Neoplasms; Female; Humans; Membrane Potential, Mitochondrial; Mitochondria; Reactive Oxygen Species; Tramadol | 2022 |
Comparison of epidural and intravenous route for acute and chronic postoperative pain control in patients with gynecological malignancy.
Topics: Analgesia, Epidural; Analgesia, Patient-Controlled; Analgesics, Opioid; Endometrial Neoplasms; Female; Genital Neoplasms, Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Pain, Postoperative; Retrospective Studies; Tramadol | 2020 |